Brava to Watros and Wright for giving us (figurative) whiplash as we watched two devoted mothers go back and forth with each ...
GH Research's inhaled psychedelic therapy GH001 has shown promise in a mid-stage trial in treatment-resistant depression (TRD), sending its shares soaring and prompting a $150 million offering to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback